Immunomediated Diseases and Innovative Therapies

< Back

Overview

The Immunomediated Diseases and Innovative Therapies is an heterogeneous area composed by both translational and clinical research groups which cover fields such as immunology, respiratory and systemic diseases, pharmacology, molecular diagnosis, heart repair, reumatology and advanced therapies. Its main strength derives precisely from this heterogeneity and the complementarity of the scientific interests and expertise of the different groups, many of which are currently joining efforts and synergizing in a variety of collaborative research projects.

Publications

214
total
1,338.943
impact factor
6.257
average impact factor

Group Leader: Luisa Ibáñez Mora

group-team team group-zoom zoom group-download download

Research Areas

The group is a Special Group of Research recognized by AGAUR GenCat. The participation in the “The European Consortium “EU PE&PV Network” (European Pharmacoepidemiology and Pharmacovigilance Network)” has been renewed. The report of the study “Characterising the risk of major bleeding in patients with Non-Valvular Atrial Fibrillation: non-interventional study of patients taking Direct Oral Anticoagulants in the EU” (EU PAS Register No: 16014) was delivered to the EMA.
A Project (Evaluación de la efectividad del tratamiento médico vía APP) led by the Pain Group has started in 2017. Some of the project outputs have been spread through the FICF twitter account @FundacioICF. The group continues the international training activities through its participation in the European master of pharmacoepidemiology (Eu2P) and hosting fellow researchers. New projects have requested the research supporting tasks of W3Nexus FICF group on standardized reporting forms and an on-line database.

VHIR Annual Report 2018

© FIR-HUVH Fundació Institut de Recerca Hospital Universitari Vall d’Hebron 2019 | Developed by: ondeuev